Zobrazeno 1 - 10
of 34
pro vyhledávání: '"39"'
Autor:
Naoyuki Nogami, Shunta Mori, Yumi Asakura, Daijiro Harada, Kenji Takata, Takayuki Ohno, Satoko Moriki, Toshiyuki Kozuki, Yoshika Takechi
Publikováno v:
Anticancer Research. 39:4987-4993
Background/aim For immune checkpoint inhibitor (ICI)-pretreated patients, docetaxel and ramucirumab (DOC+RAM) combination therapy may be more effective compared to patients not receiving ICI treatment. Patients and methods From June 2013 to July 2018
Autor:
Koji, Takada, Shinichiro, Kashiwagi, Nozomi, Iimori, Rika, Kouhashi, Akimichi, Yabumoto, Wataru, Goto, Yuka, Asano, Yukie, Tauchi, Kana, Ogisawa, Tamami, Morisaki, Masatsune, Shibutani, Hiroaki, Tanaka, Kiyoshi, Maeda
Publikováno v:
Anticancer Research. 43:191-200
Intraoperative blood loss (IBL) during the surgical treatment of various cancers affects complication rates and prognosis. However, few studies have examined the importance of minimal IBL in breast cancer surgery. We used factor analysis to examine t
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Seiichiro, Takao, Akihiro, Nishie, Yasuhiro, Ushijima, Yukihisa, Takayama, Koichiro, Morita, Keisuke, Ishimatsu, Yutaka, Koga, Yasuhisa, Mori, Yuta, Akamine, Kousei, Ishigami
Publikováno v:
Anticancer Research. 42:3895-3903
We investigated whether the malignant switch of intraductal papillary mucinous neoplasm (IPMN) of the pancreas can be predicted by using the T1ϱ, T2, and apparent diffusion coefficient (ADC) values of cyst fluid.We retrospectively analyzed the magne
Autor:
Masatoshi Matsuo, Tatsuro Jo, Kuniko Abe, Jun Taguchi, Hiroo Tominaga, Ritsuko Kubota-Koketsu, Yohei Kaneko, Shizuka Hayashi, Kazuto Shigematsu, Takahiro Sakai, Kaori Matsuzaka, Haruna Shioya
Publikováno v:
Anticancer Research. 40:5237-5243
Background/aim Adult T-cell leukemia/lymphoma (ATLL) is a relatively refractory CD4-positive peripheral T-cell lymphoma. VCAP-AMP-VECP (mLSG15) is one of the standard chemotherapeutic regimens for patients with aggressive ATLL. Mogamulizumab (moga),
Autor:
Teruki Teshima, Johannes A. Langendijk, O. Chouvalova, Masahiro Morimoto, Roel J H M Steenbakkers, Cheng-Jian Xu, Henk P. Bijl, Yasuo Yoshioka, Arjen van der Schaaf
Publikováno v:
Anticancer Research, 39(12), 6787-6798. INT INST ANTICANCER RESEARCH
BACKGROUND/AIM: The aim of this study was to develop a normal tissue complication probability (NTCP) model for trismus in head and neck cancer (HNC) patients treated with radiotherapy (RT).PATIENTS AND METHODS: Prospective measurements of maximum int
Publikováno v:
Anticancer Research. 39:1899-1906
BACKGROUND A retrospective analysis was performed to investigate the survival outcomes in adult acute lymphoblastic leukemia (ALL) based on treatment received. MATERIALS AND METHODS Data from 17,504 men and women (≥18 years of age) registered in th
Autor:
Mohammad Alyami, Olivier Glehen, Laurent Villeneuve, Frederic Mercier, Vahan Kepenekian, Nicolas Vantard, Isabelle Bonnefoy, Naoual Bakrin, Virginie Larbre, Marie-Agnès Opsomer, Catherine Rioufol
Publikováno v:
Anticancer Research. 38:6869-6875
Background/aim Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is a recent approach for intraperitoneal chemotherapy with promising results for patients with peritoneal metastasis (PM). The aim of this study was to report renal toxicity for
Autor:
Christian Krautz, Stephan Kersting, Robert Grützmann, Susanne Merkel, Maximilian Brunner, Georg F. Weber
Publikováno v:
Anticancer research. 40(5)
Background/aim The prognostic value of the number of harvested negative lymph nodes (NLNs) in patients with node-negative esophageal carcinoma treated by esophagectomy with or without neoadjuvant chemoradiation is unclear. Patients and methods A tota
Autor:
Giulia Trovarelli, Florian Pohlig, Andrea Angelini, Carolin Knebel, Ruediger von Eisenhart-Rothe, Andreas F Mavrogenis, Antonio Berizzi, Ulrich Lenze, Joerg Theisen, Pietro Ruggieri
Publikováno v:
Anticancer research. 40(3)
BACKGROUND/AIM: Chondrosarcomas (CS) of the chest wall are rare, but present an aggressive biological behavior compared to CS of the extremities. The aims of the present study were to determine factors associated with oncological outcomes as well as